ATRA vs CCI · rev $128.9M vs P/E 40, rev $6.57B
Atara Biotherapeutics Inc (ATRA) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
ATRA currently screens at market cap $87.1M. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the ATRA and CCI stock pages for the full models.
Not investment advice.